Cisplatin Plus Vinorelbine With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Elwyn Y. Loh, MD
Sanofi
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
42 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Medical Oncology Internal Medicine
Los Angeles, California, United States
- Tower Hematology Oncology Medical Group
Los Angeles, California, United States
- Bay Area Tumor Institute
Oakland, California, United States
- Medical Oncology Care Associates
Orange, California, United States
- Ucsf Cancer Center and Cancer Research Institute
San Francisco, California, United States
- John Wayne Cancer Institute
Santa Monica, California, United States
- Los Angeles County Harbor-Ucla Medical Center
Torrance, California, United States
- Medical Oncology-Hematology Consultants, P.A.
Wilmington, Delaware, United States
- Veterans Affairs Medical Center - Washington, Dc
Washington D.C., District of Columbia, United States
- Washington Cancer Institute
Washington D.C., District of Columbia, United States
- University of Florida Health Science Center - Jacksonville
Jacksonville, Florida, United States
- Watson Clinic
Lakeland, Florida, United States
- Ocala Oncology Center
Ocala, Florida, United States
- Ocala Research Institute, Inc
Ocala, Florida, United States
- Saint Alphonsus Regional Medical Center
Boise, Idaho, United States
- Dreyer Medical Clinic
Aurora, Illinois, United States
- University of Chicago Cancer Research Center
Chicago, Illinois, United States
- Northwest Oncology and Hematology, S.C.
Elk Grove Village, Illinois, United States
- Rockford Clinic
Rockford, Illinois, United States
- Cancer Care Center
New Albany, Indiana, United States
- Ccop - Northern Indiana Cr Consortium
South Bend, Indiana, United States
- Hematology-Oncology Clinic
Baton Rouge, Louisiana, United States
- University of Minnesota Cancer Center
Minneapolis, Minnesota, United States
- Capitol Comprehensive Cancer Care Clinic
Jefferson City, Missouri, United States
- Veterans Affairs Medical Center - Kansas City
Kansas City, Missouri, United States
- St. John'S Mercy Medical Center
St Louis, Missouri, United States
- Western Montana Clinic
Missoula, Montana, United States
- Veterans Affairs Medical Center - East Orange
East Orange, New Jersey, United States
- Brookdale University Hospital and Medical Center
Brooklyn, New York, United States
- Interlakes Oncology/hematology Pc
Rochester, New York, United States
- New York Medical College
Valhalla, New York, United States
- Akron General Medical Center
Akron, Ohio, United States
- Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, United States
- North Penn Hospital
Lansdale, Pennsylvania, United States
- Fox Chase - Temple Cancer Center
Philadelphia, Pennsylvania, United States
- Lone Star Oncology
Austin, Texas, United States
- Center for Oncology Research and Treatment, Medical City Hospital
Dallas, Texas, United States
- Southwest Cancer Center at University Medical Center
Lubbock, Texas, United States
- Baptist Health System Cancer Program
San Antonio, Texas, United States
- Cancer Therapy Research Center
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2000
- Primary completion
- —
- Completion
- 29 Feb 2004
- Last update posted
- 2 Aug 2013
- Registered enrollment
- —
- Registry id
- NCT00017459
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.